Proliferating cell nuclear antigen (PCNA) expression in Hodgkin's disease

Area of Science:

• Hematology
• Oncology
• Cell Biology

Background:

• Previous Hodgkin's disease (HD) research focused on classical Hodgkin and Reed-Sternberg (HRS) cells, neglecting background populations and nodular lymphocyte predominant Hodgkin's disease (NLPHD).
• Understanding cell proliferation in different HD subtypes is crucial for elucidating disease mechanisms.

Purpose of the Study:

• To determine the growth fraction of HRS and L&H cells in classical HD and NLPHD, respectively.
• To analyze the immunophenotype and proliferation of background cells in both HD types.
• To explore the relationship between classical HD and NLPHD and the role of B cells.

Main Methods:

• Utilized proliferating cell nuclear antigen (PCNA) antibody to assess cell proliferation.
• Employed double staining with anti-PCNA, CD20 (B cells), and CD45RO (T cells).
• Analyzed paraffin-embedded tissue sections from 15 classical HD and 8 NLPHD cases.

Main Results:

• Higher proliferation (76.9%) observed in L&H cells of NLPHD compared to HRS cells (50.4%) in classical HD.
• Background proliferation predominantly involved T cells (57.8% in classical HD, 68.5% in NLPHD), with minimal B cell proliferation (4%).
• Established a link between classical HD and NLPHD, suggesting altered B cells may drive disease pathology via cytokine release.

Conclusions:

• L&H cells in NLPHD exhibit higher proliferation than HRS cells in classical HD.
• T cells constitute the major proliferating background population in both HD subtypes.
• Altered B cells are implicated in the pathogenesis of both classical HD and NLPHD through cytokine production.